GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » ROC (Joel Greenblatt) %

Halberd (Halberd) ROC (Joel Greenblatt) % : -9,933.33% (As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Halberd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jul. 2023 was -9,933.33%.

The historical rank and industry rank for Halberd's ROC (Joel Greenblatt) % or its related term are showing as below:

HALB' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -9933.33   Med: -1015.05   Max: -11.46
Current: -9933.33

During the past 3 years, Halberd's highest ROC (Joel Greenblatt) % was -11.46%. The lowest was -9933.33%. And the median was -1015.05%.

HALB's ROC (Joel Greenblatt) % is ranked worse than
92.2% of 1462 companies
in the Biotechnology industry
Industry Median: -319.81 vs HALB: -9933.33

Halberd's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Halberd ROC (Joel Greenblatt) % Historical Data

The historical data trend for Halberd's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd ROC (Joel Greenblatt) % Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
ROC (Joel Greenblatt) %
-11.46 -1,015.05 -9,933.33

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
ROC (Joel Greenblatt) % -11.46 -1,015.05 -9,933.33

Competitive Comparison of Halberd's ROC (Joel Greenblatt) %

For the Biotechnology subindustry, Halberd's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Halberd's ROC (Joel Greenblatt) % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Halberd's ROC (Joel Greenblatt) % falls into.



Halberd ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jul. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.003) - (0.595 + 0 + 0)
=-0.592

Working Capital(Q: Jul. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.002) - (0.789 + 0 + 0)
=-0.787

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Halberd for the quarter that ended in Jul. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Jul. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jul. 2022  Q: Jul. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.447/( ( (0.005 + max(-0.592, 0)) + (0.004 + max(-0.787, 0)) )/ 2 )
=-0.447/( ( 0.005 + 0.004 )/ 2 )
=-0.447/0.0045
=-9,933.33 %

Note: The EBIT data used here is one times the annual (Jul. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Halberd  (OTCPK:HALB) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Halberd ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Halberd's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Halberd (Halberd) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236